COM:SANTHERA
Santhera Pharmaceuticals Switzerland
- Stock
locale
Switzerlandmarket
STOCKSindustry
Pharmaceuticalswebsite
www.santhera.com/ipo date
Mar 06, 2014
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular...Show More